Erratum: Disorders of biopterin metabolism (Journal of Inherited Metabolic Disease (2009) 10.1007/s10545-009-1067-2);Disorders of biopterin metabolism

Journal of Inherited Metabolic Disease

Volumn 32, Issue 3, 2009, Pages 333-342

  Longo, Nicola ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; 6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; BIOPTERIN; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; FOLIC ACID; FOLINIC ACID; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; NITRIC OXIDE SYNTHASE; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; SEPIAPTERIN REDUCTASE; TETRAHYDROBIOPTERIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

AGITATION; BIOPTERIN DEFICIENCY; CONFERENCE PAPER; DIET THERAPY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME DEFECT; ENZYME DEFICIENCY; GENE MUTATION; HUMAN; HYPERPHENYLALANINEMIA; LOW DRUG DOSE; MENTAL DEFICIENCY; METABOLIC DISORDER; METABOLIC REGULATION; MICROCEPHALY; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; SEIZURE; SIDE EFFECT; SPASTICITY;

EID: 67349085037     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9964-y     Document Type: Erratum

References (45)

1. Abeling NG, Duran M, Bakker HD, et al (2006) Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol Genet Metab 89 (1-2): 116-120. doi: 10.1016/j.ymgme.2006.03.010.
2. al Aqeel A, Ozand PT, Gascon GG, Hughes H, Reynolds CT, Subramanyam SB (1992) Response of 6-pyruvoyl-tetrahydropterin synthase deficiency to tetrahydrobiopterin. J Child Neurol 7 (Supplement): S26-S30.
3. Bartholomé K (1974) Letter: A new molecular defect in phenylketonuria. Lancet 304 (7896): 1580. doi: 10.1016/ S0140-6736(74)90337-7.
4. Bonafe L, Thony B, Penzien JM, Czarnecki B, Blau N (2001) Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 69 (2): 269-277. doi: 10.1086/321970.
5. Concolino D, Muzzi G, Rapsomaniki M, Moricca MT, Pascale MG, Strisciuglio P (2008) Serum prolactin as a tool for the follow-up of treated DHPR-deficient patients. J Inherit Metab Dis. doi: 10.1007/ s10545-007-0788-3.
6. Curtius HC, Adler C, Rebrin I, Heizmann C, Ghisla S (1990) 7-Substituted pterins: Formation during phenylalanine hydroxylation in the absence of dehydratase. Biochem Biophys Res Commun 172 (3): 1060-1066. doi: 10.1016/ 0006-291X(90)91554-6.
7. de Sanctis L, Alliaudi C, Spada M, et al (2000) Genotype-phenotype correlation in dihydropteridine reductase deficiency. J Inherit Metab Dis 23 (4): 333-337. doi: 10.1023/A: 1005662710891.
8. Dudešek A, Roschinger W, Muntau AC (2001) Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. Eur J Pediatr 160 (5): 267-276. doi: 10.1007/s004310000722.
9. Echenne B, Roubertie A, Assmann B (2006) Sepiapterin reductase deficiency: Clinical presentation and evaluation of long-term therapy. Pediatr Neurol 35 (5): 308-313. doi: 10.1016/j.pediatrneurol.2006.05.006.
10. Friedman J, Hyland K, Blau N, MacCollin M (2006) Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency. Neurology 67 (11): 2032-2035. doi: 10.1212/ 01.wnl.0000247274.21261.b4.
11. Hevel JM, Stewart JA, Gross KL, Ayling JE (2006) Can the DCoHalpha isozyme compensate in patients with 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH deficiency? Mol Genet Metab 88 (1): 38-46. doi: 10.1016/ j.ymgme.2005.11.014.
12. Hopkins FG (1889) Note on a yellow pigment from butterflies. Nature 40: 355.
13. Hopkins FG (1942) A contribution to the chemistry of pterins. Proc R Soc 130: 359-379.
14. Horvath GA, Stockler-Ipsiroglu SG, Salvarinova-Zivkovic R, et al (2008) Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: Evidence of a phenotypic continuum between dominant and recessive forms. Mol Genet Metab 94 (1): 127-131. doi: 10.1016/j.ymgme.2008.01.003.
15. Hyland K (2007) Inherited disorders affecting dopamine and serotonin: critical neurotransmitters derived from aromatic amino acids. J Nutr 137 (6 Supplement 1): 1568S-1572S; discussion 1573S-1575S.
16. Hyland K (2008) Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid. Clin Chem 54 (4): 633-641. doi: 10.1373/clinchem.2007.099986.
17. Irons M, Levy HL, O'Flynn ME, et al (1987) Folinic acid therapy in treatment of dihydropteridine reductase deficiency. J Pediatr 110 (1): 61-67. doi: 10.1016/S0022-3476(87)80289-5.
18. Jaggi L, Zurfluh MR, Schuler A, et al (2008) Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol Genet Metab 93 (3): 295-305. doi: 10.1016/j.ymgme.2007.10.004.
19. Katusic ZS, d'Uscio LV, Nath KA (2009) Vascular protection by tetrahydrobiopterin: Progress and therapeutic prospects. Trends Pharmacol Sci 30 (1): 48-54.
20. Kaufman S (1963) The structure of the phenylalanine-hydroxylation cofactor. Proc Natl Acad Sci U S A 50: 1085-1093. doi: 10.1073/ pnas.50.6.1085.
21. Kaufman S, Holtzman NA, Milstien S, Butler LJ, Krumholz A (1975) Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med 293 (16): 785-790.
22. Kaufman S, Berlow S, Summer GK, et al (1978) Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med 299 (13): 673-679.
23. Kaufman S, Kapatos G, McInnes RR, Schulman JD, Rizzo WB (1982) Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: Evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics 70 (3): 376-380.
24. Komori H, Matsuishi T, Yamada S, Yamashita Y, Ohtaki E, Kato H (1995) Cerebrospinal fluid biopterin and biogenic amine metabolites during oral R-THBP therapy for infantile autism. J Autism Dev Disord 25 (2): 183-193. doi: 10.1007/BF02178503.
25. Lee NC, Cheng LY, Liu TT, Hsiao KJ, Chiu PC, Niu DM (2006) Long-term follow-up of Chinese patients who received delayed treatment for 6-pyruvoyl-tetrahydropterin synthase deficiency. Mol Genet Metab 87 (2): 128-134. doi: 10.1016/j.ymgme.2005.09.028.
26. Liu KM, Liu TT, Lee NC, Cheng LY, Hsiao KJ, Niu DM (2008) Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency. Arch Neurol 65 (3): 387-392. doi: 10.1001/archneur.65.3.387.
27. Longhi R, Valsasina R, Butte C, Paccanelli S, Riva E, Giovannini M (1985) Cranial computerized tomography in dihydropteridine reductase deficiency. J Inherit Metab Dis 8 (3): 109-112. doi: 10.1007/BF01819291.
28. Maita N, Okada K, Hatakeyama K, Hakoshima T (2002) Crystal structure of the stimulatory complex of GTP cyclohydrolase I and its feedback regulatory protein GFRP. Proc Natl Acad Sci U S A 99 (3): 1212-1217. doi: 10.1073/pnas.022646999.
29. Neville BG, Parascandalo R, Farrugia R, Felice A (2005) Sepiapterin reductase deficiency: A congenital dopa-responsive motor and cognitive disorder. Brain 128 (Pt 10): 2291-2296. doi: 10.1093/brain/awh603.
30. Niederwieser A, Blau N, Wang M, Joller P, Atares M, Cardesa-Garcia J (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr 141 (4): 208-214. doi: 10.1007/BF00572762.
31. Ogawa A, Kanazawa M, Takayanagi M, Kitani Y, Shintaku H, Kohno Y (2008) A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels. Brain Dev 30 (1): 82-85. doi: 10.1016/j.braindev.2007.05.011.
32. Rey F, Blandin-Savoja F, Rey J (1976) Atypical phenylketonuria with normal dihydropteridine reductase activity. N Engl J Med 295 (20): 1138-1139.
33. Schaub J, Daumling S, Curtius HC (1978) Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis. Arch Dis Child 53 (8): 674-676.
34. Schircks B, Bieri JH, Viscontini M (1976) Preparation and characterisation of pure 5,6,7,8-tetrahydro-L-neopterine and 5,6,7,8-tetrahydro-D-monapterine (author's transl). Helv Chim Acta 59 (1): 248-252. doi: 10.1002/hlca.19760590128.
35. Schmidt TS, Alp NJ (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 113 (2): 47-63.
36. Schopf C (1964) Die Anfange der Pterinchemie. In: Pfleiderer W, Taylor, E.D., eds. Pteridine Chemistry. Oxford: Pergamon Press, 3-14.
37. Smith I, Clayton BE, Wolff OH (1975) New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet 305 (7916): 1108-1111. doi: 10.1016/ S0140-6736(75)92498-8.
38. Smith I, Hyland K, Kendall B (1985) Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. J Inherit Metab Dis 8 (Supplement 1): 39-45. doi: 10.1007/BF01800658.
39. Spada M, Ferraris S, Ferrero GB (1996) Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactin. J Inherit Metab Dis 19 (2): 231-233. doi: 10.1007/BF01799437.
40. Thony B, Blau N (2006) Mutations in the BH 4 -metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 27 (9): 870-878. doi: 10.1002/humu.20366.
41. Thöny B, Neuheiser F, Kierat L, et al (1998) Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia. Hum Genet 103 (2): 162-167. doi: 10.1007/ s004390050800.
42. Watschinger K, Keller MA, Hermetter A, Golderer G, Werner-Felmayer G, Werner ER (2009) Glyceryl ether monooxygenase resembles aromatic amino acid hydroxylases in metal ion and tetrahydrobiopterin dependence. Biol Chem 390 (1): 3-10.
43. Woody RC, Brewster MA, Glasier C (1989) Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy. Neurology 39 (5): 673-675.
44. Yang S, Lee YJ, Kim JM, et al (2006) A murine model for human sepiapterin-reductase deficiency. Am J Hum Genet 78 (4): 575-587. doi: 10.1086/501372.
45. Zorzi G, Redweik U, Trippe H, Penzien JM, Thony B, Blau N (2002) Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency. Mol Genet Metab 75 (2): 174-177. doi: 10.1006/mgme.2001.3273.